Allergan Swoops in and Bags Troubled Repros Therapeutics Post author:Sam Post published:December 11, 2017 Post category:BioPharma The deal is expected to close in the first quarter of 2018. Source: BioSpace You Might Also Like 4 Large Cap Pharmas That Could Post Huge Earnings October 19, 2017 Glaukos Completes Patient Enrollment In Pivotal Phase Of U.S. IDE Clinical Trial For iStent SUPRA February 15, 2017 AstraZeneca PLC Eases Its Migraine With $302 Million Sale June 6, 2017
Glaukos Completes Patient Enrollment In Pivotal Phase Of U.S. IDE Clinical Trial For iStent SUPRA February 15, 2017
